Circulating miRNA‑21 is a promising biomarker for heart failure

  • Authors:
    • Jianghua Zhang
    • Qiang Xing
    • Xianhui Zhou
    • Jinxin Li
    • Yaodong Li
    • Lin Zhang
    • Qina Zhou
    • Baopeng Tang
  • View Affiliations

  • Published online on: September 21, 2017     https://doi.org/10.3892/mmr.2017.7575
  • Pages: 7766-7774
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

microRNA 21 (miRNA‑21) promotes the development of cardiac fibrosis, hypertrophy and heart failure. However, whether it can be used as a biomarker for the diagnosis and prognosis of heart failure remains unclear. The current study assessed circulating miRNA‑21 as a viable indicator for diagnosis and prognosis of heart failure. The levels of miRNA‑21 and brain natriuretic peptide were measured in serum obtained from the peripheral vein (miRNA‑21‑PV) and coronary sinus (miRNA‑21‑CS) of 80 patients with heart failure and 40 control individuals via reverse transcription‑quantitative polymerase chain reaction and ELISA, respectively. The correlations between circulating miRNA‑21 and diagnosis, severity, prognosis and re‑hospitalization rate of heart failure were evaluated using statistical analysis. Serum miRNA‑21‑PV and miRNA‑21‑CS levels of patients with heart failure were significantly higher than that of control subjects, and were also correlated with ejection fraction and brain natriuretic peptide. Both were determined to have high levels of sensitivity and specificity for diagnosing heart failure. Follow‑up of the patients with heart failure indicated that miRNA‑21‑PV and miRNA‑21‑CS were correlated with prognosis, and miRNA‑21‑CS was efficient in predicting re‑hospitalization for heart failure. Circulating miRNA‑21 has potential to be a biomarker of heart failure.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 16 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Xing Q, Zhou X, Li J, Li Y, Zhang L, Zhou Q and Tang B: Circulating miRNA‑21 is a promising biomarker for heart failure. Mol Med Rep 16: 7766-7774, 2017.
APA
Zhang, J., Xing, Q., Zhou, X., Li, J., Li, Y., Zhang, L. ... Tang, B. (2017). Circulating miRNA‑21 is a promising biomarker for heart failure. Molecular Medicine Reports, 16, 7766-7774. https://doi.org/10.3892/mmr.2017.7575
MLA
Zhang, J., Xing, Q., Zhou, X., Li, J., Li, Y., Zhang, L., Zhou, Q., Tang, B."Circulating miRNA‑21 is a promising biomarker for heart failure". Molecular Medicine Reports 16.5 (2017): 7766-7774.
Chicago
Zhang, J., Xing, Q., Zhou, X., Li, J., Li, Y., Zhang, L., Zhou, Q., Tang, B."Circulating miRNA‑21 is a promising biomarker for heart failure". Molecular Medicine Reports 16, no. 5 (2017): 7766-7774. https://doi.org/10.3892/mmr.2017.7575